Allarity Therapeutics is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes.

Allarity Therapeutics, Inc. announced it raised $20 Million in an initial filing from an offering of $40 Million

Company Information

Related People

Funding Insights

Allarity Therapeutics, Inc. announced it raised $20 Million in an initial filing from an offering of $40 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information